Publishing Service

Polishing & Checking

Journal of Zhejiang University SCIENCE B

ISSN 1673-1581(Print), 1862-1783(Online), Monthly

2012 Vol.13 No.8 P.609-615

Clinical considerations of anticoagulation therapy for patients with atrial fibrillation

Shu Zhang

Arrhythmias Center and Clinical EP Lab., Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China

zsfuwai@vip.163.com

Abstract: Atrial fibrillation (AF) increases the risk of stroke. New anticoagulation agents have recently provided alternative and promising approaches. This paper reviews the current state of anticoagulation therapy in AF patients, focusing on various clinical scenarios and on comparisons, where possible, between western and eastern populations.

Key words: Anticoagulation therapy, Atrial fibrillation, Warfarin, Dabigatran, Riveroxaban, Apixaban


Share this article to： More

Go to Contents

Recommended Papers Related to this topic:

<HIDE>

[1]Jiang, K., Huang, C., Ye, S.M., Chen, H., 2012. High accuracy in automatic detection of atrial fibrillation for Holter monitoring. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), in press.

References:

<Show All>

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





DOI:

10.1631/jzus.B1201007

CLC number:

R541.7+5

Download Full Text:

Click Here

Downloaded:

3026

Clicked:

5744

Cited:

4

On-line Access:

2024-08-27

Received:

2023-10-17

Revision Accepted:

2024-05-08

Crosschecked:

2012-07-17

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952276; Fax: +86-571-87952331; E-mail: jzus@zju.edu.cn
Copyright © 2000~ Journal of Zhejiang University-SCIENCE